August 24, 2020 — Scientists in Hong Kong say they’ve confirmed that a person can be infected with COVID-19 two times.

There have been sporadic accounts on social media web pages of individuals who say they’ve gotten COVID two times. But researchers have been skeptical about that risk, declaring there’s no proof it transpires.

The new proof arrives from a 33-year-old gentleman in Hong Kong who very first caught COVID-19 in March. He was analyzed for the coronavirus after he created a cough, sore throat, fever, and a headache for 3 days. He stayed in the healthcare facility till he two times analyzed adverse for the virus in mid-April.

On Aug. 15, the gentleman returned to Hong Kong from a new vacation to Spain and the U.K., spots that have not long ago witnessed a resurgence of COVID-19 cases. At the airport, he was screened for COVID-19 employing a test that checks saliva for the virus. He analyzed beneficial, but this time, had no signs. He was taken to the healthcare facility for checking. His viral load — the amount of money of virus he had in his overall body — went down about time, suggesting that his immune procedure was having care of the intrusion on its have.

The distinctive point about his circumstance is that each individual time he was hospitalized, doctors sequenced the genome of the virus that infected him. It was a bit distinct from a single an infection to the upcoming, suggesting that the virus had mutated — or changed — in the four months involving his bacterial infections. It also proves that it’s achievable for this coronavirus to infect the similar person two times.

Experts with the Planet Health and fitness Business responded to the circumstance at a news briefing Monday.

“What we are studying about an infection is that individuals do acquire an immune reaction. What is not absolutely distinct nonetheless is how robust that immune reaction is and for how extensive that immune reaction lasts,” explained Maria Van Kerkhove, PhD, an infectious sickness epidemiologist with the Planet Health and fitness Business in Geneva, Switzerland.

A research on the man’s circumstance is getting ready for publication in the journal Clinical Infectious Diseases. Experts say the discovering shouldn’t lead to alarm, but it does have crucial implications for the progress of herd immunity and attempts to appear up with vaccines and remedies.

“This appears to be quite distinct-lower proof of reinfection for the reason that of sequencing and isolation of two distinct viruses,” says Gregory Poland, MD, an specialist on vaccine progress and immunology at the Mayo Clinic in Rochester, MN. “The major mysterious is how typically is this happening,” he says. A lot more research are desired to understand irrespective of whether this was a uncommon circumstance or a little something that is happening typically.

Earlier Practical experience Guides Existing

Until finally we know additional, Poland says the risk of acquiring COVID-19 two times shouldn’t make any one be concerned.

This also transpires with other kinds of coronaviruses — the kinds that lead to typical colds. Individuals coronaviruses modify a bit each individual year as they circle the world, which enables them to keep spreading and creating their additional operate-of-the-mill variety of distress.

It also transpires with seasonal flu. It is the motive individuals have to get vaccinated towards the flu year after year, and why the flu vaccine has to modify a bit each individual year in an energy to keep up with the ever-evolving influenza virus.

“We’ve been creating flu vaccines for eighty yrs, and there are scientific trials happening as we communicate to uncover new and far better influenza vaccines,” Poland says.

There has been other proof the virus that leads to COVID-19 can modify this way, too. Scientists at Howard Hughes Healthcare Centre, at Rockefeller University in New York, not long ago employed a vital piece of the SARS-CoV-2 virus — the genetic directions for its spike protein — to consistently infect human cells. Experts viewed as each individual new era of the virus went on to infect a new batch of cells. In excess of time, as it copied itself, some of the copies changed their genes to let them to endure after researchers attacked them with neutralizing antibodies. Individuals antibodies are a single of the key weapons employed by the immune procedure to acknowledge and disable a virus.

Nevertheless that research is however a preprint, which signifies it hasn’t nonetheless been reviewed by outside the house specialists, the authors wrote that their conclusions propose the virus can modify in means that assistance it evade our immune procedure. If accurate, they wrote in mid-July, it signifies reinfection is achievable, specially in individuals who have a weak immune reaction to the virus the very first time they encounter it.

Superior News

That looks to be accurate in the circumstance of the gentleman from Hong Kong. When doctors analyzed his blood to appear for antibodies to the virus, they did not uncover any. That could imply that he both had a weak immune reaction to the virus the very first time about, or that the antibodies he manufactured during his very first an infection diminished about time. But during his 2nd an infection, he immediately created additional antibodies, suggesting that the 2nd an infection acted a tiny little bit like a booster to fireplace up his immune procedure. That is likely the motive he did not have any signs the 2nd time, too.

That is fantastic news, Poland says. It signifies our bodies can get far better at combating off the COVID-19 virus and that catching it as soon as signifies the 2nd time could not be so bad.

But the actuality that the virus can modify immediately this way does have some influence on the energy to appear up with a vaccine that will work well.

“I believe a prospective implication of this is that we will have to give booster doses. The dilemma is how commonly,” Poland says. That will rely on how fast the virus is transforming, and how typically reinfection is happening in the serious world.

“I’m a tiny surprised at 4½ months,” Poland says, referencing the time involving the Hong Kong man’s bacterial infections. “I’m not surprised by, you know, I got infected final winter and I got infected once again this winter,” he says.

It also suggests that immune-primarily based therapies these as convalescent plasma and monoclonal antibodies may well be of minimal assistance about time, because the virus could be transforming in means that assistance it outsmart all those remedies.

Convalescent plasma is in essence a concentrated dose of antibodies from individuals who have recovered from a COVID-19 an infection. As the virus improvements, the antibodies in that plasma may well not get the job done as well for future bacterial infections.

Drug companies have uncovered to harness the energy of monoclonal antibodies as highly effective remedies towards most cancers and other conditions. Monoclonal antibodies, which are mass-created in a lab, mimic the body’s pure defenses towards a pathogen. Just like the virus can come to be resistant to pure immunity, it can modify in means that assistance it outsmart lab-designed remedies. Some drug companies that are producing monoclonal antibodies to fight COVID-19 have presently ready for that risk by creating antibody cocktails that are created to disable the virus by locking on to it in distinct sites, which may well assistance stop it from producing resistance to all those therapies.

“We have a whole lot to understand,” Poland says. “Now that the proof of theory has been proven, and I would say it has with this gentleman, and with our know-how of seasonal coronaviruses, we have to have to appear additional aggressively to define how typically this occurs.”


Clinical Infectious Diseases, Aug. 24, 2020.

Gregory Poland, MD, specialist, Division of Pediatric Infectious Diseases specialist, Office of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN.

Maria Van Kerkhove, PhD, infectious sickness epidemiologist, Planet Health and fitness Business, Geneva, Switzerland.

© 2020 WebMD, LLC. All legal rights reserved.